Teza Capital Management LLC Pacira Bio Sciences, Inc. Transaction History
Teza Capital Management LLC
- $645 Million
- Q4 2024
A detailed history of Teza Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Teza Capital Management LLC holds 13,417 shares of PCRX stock, worth $315,433. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,417
Previous 15,589
13.93%
Holding current value
$315,433
Previous $234,000
7.69%
% of portfolio
0.04%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$188 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$124 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$76.7 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$53.1 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$46.8 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.08B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...